One of the missions at the CIB Margarita Salas-CSIC consists in making available to society the knowledge and the research results generated in our research center. Thus, we aim to convert our basic research findings into tangible applications, either through the generation and licensing of intellectual property, and/or through the generation of spin-off companies. Currently the CIB Margarita Salas has 8 EBTs considered CSIC spin-offs: Secugen, Protein alternatives, Lifesequencing (now ADM-Lifesequencing), Ankar Pharma, Abvance Biotech, Arrays for Cell Nanodevices (A4CELL), Microbial Biosystems and AItenea Biotech. In addition, HelpRare is in the process to become a EBT in the coming months and we also had recently the spin-off ProRetina Therapeutics, which closed last year (2007-2019).


Secugen logo                lifesequencing logo


Ankar Pharma logo        Abvance


      Proalt Alternatives logo             A4Cell logo


                 Microbial B logo


                          AItenea logo


                                Help Rare logo